Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Speaker announcement
: First Lady Jill Biden to Speak at Fierce JPM Week on January 14th
pancreatic cancer
Pharma
Merus' Bizengri wins FDA nod as 1st drug to target NRG1+ cancers
The FDA had originally pushed its decision back by three months after a November manufacturing-related delay.
Zoey Becker
Dec 4, 2024 6:55pm
PCI and ChiRhoClin partner to foil shortage of diagnostic drug
Nov 20, 2024 9:30am
Ipsen's Onivyde combo approved in first-line pancreatic cancer
Feb 13, 2024 4:31pm
Exelixis ends Cabometyx study after seeing dramatic improvements
Aug 24, 2023 12:54pm
Ipsen's Onivyde turns in positive results in pancreatic cancer
Jan 20, 2023 11:21am
Ipsen's Onivyde pushes for earlier pancreatic cancer
Nov 9, 2022 12:16pm
